![JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience](https://www.mdpi.com/jcm/jcm-12-02429/article_deploy/html/images/jcm-12-02429-g002.png)
JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
![145th Annual Meeting American Neurological Association - 2020 - Annals of Neurology - Wiley Online Library 145th Annual Meeting American Neurological Association - 2020 - Annals of Neurology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0c51dfdd-941f-4680-bf96-c3d43ba130ab/ana.v88.s25.cover.jpg)
145th Annual Meeting American Neurological Association - 2020 - Annals of Neurology - Wiley Online Library
![Frontiers | Relatively Early and Late-Onset Neuromyelitis Optica Spectrum Disorder in Central China: Clinical Characteristics and Prognostic Features Frontiers | Relatively Early and Late-Onset Neuromyelitis Optica Spectrum Disorder in Central China: Clinical Characteristics and Prognostic Features](https://www.frontiersin.org/files/Articles/859276/fneur-13-859276-HTML/image_m/fneur-13-859276-g005.jpg)
Frontiers | Relatively Early and Late-Onset Neuromyelitis Optica Spectrum Disorder in Central China: Clinical Characteristics and Prognostic Features
![JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience](https://www.mdpi.com/jcm/jcm-12-02429/article_deploy/html/images/jcm-12-02429-g003.png)
JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
![JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience](https://www.mdpi.com/jcm/jcm-12-02429/article_deploy/html/images/jcm-12-02429-g002-550.jpg)
JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
Troll With Common Sense - FACT:- 🎤 The commentator during the game between Barcelona & Juventus: "You can always debate who is better between them, but when it comes to delivering on
![JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience JCM | Free Full-Text | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience](https://pub.mdpi-res.com/jcm/jcm-12-02429/article_deploy/html/images/jcm-12-02429-g001-550.jpg?1679458971)